[go: up one dir, main page]

GB201605217D0 - New uses and methods - Google Patents

New uses and methods

Info

Publication number
GB201605217D0
GB201605217D0 GBGB1605217.7A GB201605217A GB201605217D0 GB 201605217 D0 GB201605217 D0 GB 201605217D0 GB 201605217 A GB201605217 A GB 201605217A GB 201605217 D0 GB201605217 D0 GB 201605217D0
Authority
GB
United Kingdom
Prior art keywords
methods
new uses
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1605217.7A
Other versions
GB2548839B (en
GB2548839A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Great Matter Pharma AB
Original Assignee
Pavlov Pavel And Winblad Bengt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pavlov Pavel And Winblad Bengt filed Critical Pavlov Pavel And Winblad Bengt
Priority to GB1605217.7A priority Critical patent/GB2548839B/en
Publication of GB201605217D0 publication Critical patent/GB201605217D0/en
Priority to PCT/GB2017/050866 priority patent/WO2017168137A1/en
Publication of GB2548839A publication Critical patent/GB2548839A/en
Application granted granted Critical
Publication of GB2548839B publication Critical patent/GB2548839B/en
Withdrawn - After Issue legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1605217.7A 2016-03-29 2016-03-29 New uses and methods Withdrawn - After Issue GB2548839B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1605217.7A GB2548839B (en) 2016-03-29 2016-03-29 New uses and methods
PCT/GB2017/050866 WO2017168137A1 (en) 2016-03-29 2017-03-28 Pyrimidobenzimidazoles for use in the treatment and prevention of neurodegenerative disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1605217.7A GB2548839B (en) 2016-03-29 2016-03-29 New uses and methods

Publications (3)

Publication Number Publication Date
GB201605217D0 true GB201605217D0 (en) 2016-05-11
GB2548839A GB2548839A (en) 2017-10-04
GB2548839B GB2548839B (en) 2021-02-24

Family

ID=56027495

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1605217.7A Withdrawn - After Issue GB2548839B (en) 2016-03-29 2016-03-29 New uses and methods

Country Status (2)

Country Link
GB (1) GB2548839B (en)
WO (1) WO2017168137A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108250202B (en) * 2018-01-15 2019-10-25 陕西师范大学 2,3-disubstituted benzimidazolo[1,2-a]pyrimidines and their preparation methods and applications
CN108690027B (en) * 2018-06-15 2019-09-27 广州大学 A 2-difluoromethylene substituted pyrimido[1,2-a]benzimidazole compound and its preparation and application
MX2021013574A (en) 2019-05-09 2021-12-10 Hoffmann La Roche SYNTHESIS OF LABELED IMIDAZO[1,2-A]PYRIMIDINES.
US20210128561A1 (en) * 2019-10-31 2021-05-06 Rheinische-Friedrich-Wilhelms-Universität Bonn MRGX Receptor Antagonists
WO2022111473A1 (en) * 2020-11-26 2022-06-02 Bioardis Llc Compounds as mrgprx2 antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072679A (en) * 1976-06-15 1978-02-07 E. R. Squibb & Sons, Inc. 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides
RU2042679C1 (en) * 1993-06-15 1995-08-27 Курский Государственный Медицинский Институт 10-benzyl-2-hydroxy-4-oxo-4h-pyrimido-[1,2-a]-benzimidazole showing neuroleptic, anticonvulsant, antihypoxic, analgetic and antinociceptic activities
FR2872165B1 (en) * 2004-06-24 2006-09-22 Sod Conseils Rech Applic NEW PYRIMIDO-BENZIMIDAZOLE DERIVATIVES
US8119647B2 (en) * 2008-04-23 2012-02-21 Glenmark Pharmaceuticals S.A. Fused pyrimidineone compounds as TRPV3 modulators
EP2138498A1 (en) * 2008-06-26 2009-12-30 sanofi-aventis Substituted tricyclic derivatives against neurodegenerative diseases

Also Published As

Publication number Publication date
GB2548839B (en) 2021-02-24
GB2548839A (en) 2017-10-04
WO2017168137A1 (en) 2017-10-05

Similar Documents

Publication Publication Date Title
IL255577B (en) Tigit-binding agents and uses thereof
IL253433A0 (en) Tnfrsf-binding agents and uses thereof
IL252216A0 (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
IL247014A0 (en) 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof
IL264813B (en) 2-oxo-imidazopyridines and their use
PL3152226T3 (en) Modified cyclopentapeptides and uses thereof
IL297057B1 (en) Combinations and uses thereof
SG11201704473WA (en) New methods and uses
GB201603311D0 (en) New uses and methods
GB201612858D0 (en) New uses and methods
GB201608779D0 (en) Methods and compounds
GB2560211B (en) Methods and devices
PL3565374T3 (en) Region configuration methods and devices
GB201608776D0 (en) Methods and compounds
GB2548839B (en) New uses and methods
IL254241A0 (en) Etv2 and uses thereof
GB201517786D0 (en) Methods and materials
GB201408091D0 (en) Methods and uses
GB201513590D0 (en) Devices and methods
GB201416082D0 (en) Method and uses
GB2545167B (en) Cloches and use thereof
GB201614874D0 (en) New compounds and uses
GB201512216D0 (en) Agents uses and methods
GB201416086D0 (en) Methods and uses
GB201416073D0 (en) Methods and uses

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: GREAT MATTER PHARMA AB

Free format text: FORMER OWNERS: PAVEL PAVLOV;BENGT WINBLAD

S29 Surrender of patent (sect. 29/pat. act 1977)

Free format text: OFFER FILED; APPLICATION FILED 01 DECEMBER 2021

S29 Surrender of patent (sect. 29/pat. act 1977)

Free format text: OFFER ACCEPTED